Q1 FY27 Results: Consolidated Revenue Up 251% YoY, PAT at Rs 25.14 Lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue from operations jumped to Rs 1,001.91 lakh in Q1 FY27 from Rs 285.35 lakh YoY, a 251% rise. Consolidated PAT grew 125% YoY to Rs 25.14 lakh (EPS Rs 0.23 vs Rs 0.10). Growth driven by subsidiary KP International. Standalone results remain weak with revenue at Rs 23.53 lakh and a loss of Rs 5.74 lakh. Auditor issued an unqualified limited review report.
Strong consolidated growth shows subsidiary business scaling up, but standalone losses signal pressure on the parent business.